£45M Dementia Drug Discovery Funding for UK Universities Alliance
Alzheimer's Research UK invests £45m in the Drug Discovery Alliance at Cambridge, Oxford, and UCL, advancing dementia therapies from university labs to clinical trials.
higher-education-researchresearch-publication-newsdementia-research

